[High-dose melphalan in patients with multiple myeloma]. / Intensification thérapeutique par le melphalan à haute dose dans le myélome.
Bull Cancer
; 86(3): 283-8, 1999 Mar.
Article
en Fr
| MEDLINE
| ID: mdl-10210762
ABSTRACT
Since 1983 an increasing number of clinical trials have used high-dose melphalan with or without autologous stem cell support in patients with multiple myeloma. It has been shown that high-dose therapy including high-dose melphalan may be considered as the treatment of choice in newly diagnosed patients. The purpose of this report is to review and summarize the clinical information on IV high-dose melphalan in patients with multiple myeloma and to examine potential areas of future investigation.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Trasplante de Células Madre Hematopoyéticas
/
Antineoplásicos Alquilantes
/
Melfalán
/
Mieloma Múltiple
Límite:
Humans
Idioma:
Fr
Revista:
Bull Cancer
Año:
1999
Tipo del documento:
Article